Markets

  1. Home
Market Nav

RATIO ANALYSIS

You can view the ratio analysis for the last 5 years.
Welcure Drugs & Pharmaceuticals Ltd.
GO
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)0.36-0.120.080.020.05
Diluted EPS (Rs.)0.36-0.120.080.020.05
Cash EPS (Rs.)0.01-0.100.070.010.04
Book Value[Excl.RevalReserv]/Share (Rs.)0.910.991.130.070.05
Book Value[Incl.RevalReserv]/Share (Rs.)0.910.991.130.070.05
Revenue From Operations / Share (Rs.)0.210.000.000.080.10
PBDIT / Share (Rs.)0.02-0.100.070.010.04
PBIT / Share (Rs.)0.02-0.120.070.010.04
PBT / Share (Rs.)0.02-0.120.070.010.04
Net Profit / Share (Rs.)0.01-0.120.070.010.04
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)11.350.000.0022.4541.33
PBIT Margin (%)11.320.000.0022.4541.33
PBT Margin (%)11.320.000.0022.4541.33
Net Profit Margin (%)8.830.000.0022.4541.33
Return on Networth / Equity (%)2.11-12.976.7125.3579.39
Return on Capital Employeed (%)1.23-12.976.7125.3579.39
Return On Assets (%)0.81-12.696.6524.3575.47
Long Term Debt / Equity (X)1.200.000.000.000.00
Total Debt / Equity (X)1.200.000.000.000.00
Asset Turnover Ratio (%)0.180.000.001.242.73
      
LIQUIDITY RATIOS     
      
Current Ratio (X)4.411.130.4317.3020.28
Quick Ratio (X)0.931.130.4317.3020.28
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)1145.145.035.4011.772.23
EV / Net Operating Revenue (X)46.650.000.00112.1316.74
EV / EBITDA (X)410.78-36.1851.47499.3340.49
MarketCap / Net Operating Revenue (X)41.630.000.00112.7617.09
Price / BV (X)9.973.773.57128.5532.98
Price / Net Operating Revenue (X)41.640.000.00113.6017.25
EarningsYield0.00-0.030.010.000.02